Plus Therapeutics to present groundbreaking CNS cancer treatment data at 2024 neuro-oncology conference in Texas
Plus Therapeutics a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, will have multiple opportunities to present data at the… read more.